Biotalys N.V [BTLS] vs Syneos Health [SYENS] Detailed Stock Comparison

Biotalys N.V.

EURONEXT
Loading...

Syneos Health, Inc.

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Biotalys N.V. wins in 3 metrics, Syneos Health, Inc. wins in 14 metrics, with 0 ties. Syneos Health, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Biotalys N.V. Syneos Health, Inc. Better
P/E Ratio (TTM) -5.82 377.86 Syneos Health, Inc.
Price-to-Book Ratio 4.40 0.94 Syneos Health, Inc.
Debt-to-Equity Ratio 21.67 48.61 Biotalys N.V.
PEG Ratio -13.12 28.45 Syneos Health, Inc.
EV/EBITDA -5.28 6.44 Syneos Health, Inc.
Profit Margin (TTM) 0.00% -1.04% Biotalys N.V.
Operating Margin (TTM) -589.49% 4.55% Syneos Health, Inc.
EBITDA Margin (TTM) N/A 4.55% N/A
Return on Equity -75.33% -1.25% Syneos Health, Inc.
Return on Assets (TTM) -32.17% 2.60% Syneos Health, Inc.
Free Cash Flow (TTM) $-12.79M $243.00M Syneos Health, Inc.
1-Year Return -26.17% -0.90% Syneos Health, Inc.
Price-to-Sales Ratio (TTM) -1,199.11 0.96 Syneos Health, Inc.
Enterprise Value $73.77M $7.75B Syneos Health, Inc.
EV/Revenue Ratio -1,010.61 1.30 Syneos Health, Inc.
Gross Profit Margin (TTM) N/A 27.96% N/A
Revenue per Share (TTM) $0 $58 Syneos Health, Inc.
Earnings per Share (Diluted) $-0.42 $-0.85 Biotalys N.V.
Beta (Stock Volatility) 1.01 0.13 Syneos Health, Inc.

Biotalys N.V. vs Syneos Health, Inc. Stock Performance Analysis

Loading Price Chart...

BTLS
SYENS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Biotalys N.V.1.74%3.88%12.24%25.88%-9.83%-11.08%
Syneos Health, Inc.1.66%6.05%7.23%51.55%-3.98%-3.46%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Biotalys N.V.-26.17%-46.80%-54.86%-54.86%-54.86%-54.86%
Syneos Health, Inc.-0.90%-29.74%-29.74%-29.74%-29.74%-29.74%

Performance & Financial Health Analysis: Biotalys N.V. vs Syneos Health, Inc.

MetricBTLSSYENS
Market Information
Market Cap i€87.53M€5.71B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i38,259144,350
90 Day Avg. Volume i61,645239,444
Last Close€3.21€67.50
52 Week Range€1.56 - €5.50€41.76 - €82.12
% from 52W High-41.55%-17.80%
All-Time High€7.98 (Jun 28, 2021)€109.90 (Dec 11, 2023)
% from All-Time High-59.77%-38.58%
Growth Metrics
Quarterly Revenue Growth-0.53%-0.17%
Quarterly Earnings GrowthN/A-0.17%
Financial Health
Profit Margin (TTM) i0.00%-0.01%
Operating Margin (TTM) i-5.89%0.05%
Return on Equity (TTM) i-0.75%-0.01%
Debt to Equity (MRQ) i21.6748.61
Cash & Liquidity
Book Value per Share (MRQ)€0.53€59.38
Cash per Share (MRQ)€0.48€9.34
Operating Cash Flow (TTM) i€-12,216,000€779.00M
Levered Free Cash Flow (TTM) i€-4,313,875€449.38M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Biotalys N.V. vs Syneos Health, Inc.

MetricBTLS (Apr 26, 2026)SYENS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-5.82377.86
Forward P/E i-13.1213.10
PEG Ratio i-13.1228.45
Price to Sales (TTM) i-1,199.110.96
Price to Book (MRQ) i4.400.94
Market Capitalization
Market Capitalization i€87.53M€5.71B
Enterprise Value i€73.77M€7.75B
Enterprise Value Metrics
Enterprise to Revenue i-1,010.611.30
Enterprise to EBITDA i-5.286.44
Risk & Other Metrics
Beta i1.010.13
Book Value per Share (MRQ) i€0.53€59.38

Financial Statements Comparison: Biotalys N.V. vs Syneos Health, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBTLS (2024)SYENS (2025)
Revenue/Sales i05.97B
Cost of Goods Sold iN/A4.12B
COGS % of Revenue i-69.1%
Gross Profit iN/A1.85B
Gross Margin i-30.9%
Research & Development i10.96M295.00M
Operating Income (EBIT) i-13.49M512.00M
Operating Margin i-8.6%
EBITDA i-11.16M1.23B
EBITDA Margin i-20.5%
Pre-Tax Income i-13.15M42.00M
Pre-Tax Income % of Revenue i-0.7%
Income Tax i40,000127.00M
Income Tax % of Revenue i-2.1%
Net Income (Profit) i-13.19M-60.00M
Profit Margin i--1.0%

Balance Sheet & Liquidity Metrics

MetricBTLS (2024)SYENS (2025)
Cash & Equivalents i22.64M861.00M
Total Current Assets i26.24M3.30B
Total Current Assets % of Revenue i-55.2%
Total Current Liabilities i4.77M1.57B
Total Current Liabilities % of Revenue i-26.4%
Long-Term Debt i3.69M2.86B
Long-Term Debt % of Revenue i-47.9%
Total Shareholders Equity i27.61M6.09B
Retained Earnings i-11.72M4.50B
Retained Earnings % of Revenue i-75.3%
Property, Plant & Equipment i7.04M376.00M

Cash Flow Statement Comparison

MetricBTLS (2024)SYENS (2025)
Operating Cash Flow i-13.76M149.00M
Operating Cash Flow % of Revenue i-2.5%
Capital Expenditures i-107,000-427.00M
Free Cash Flow i-12.79M243.00M
FCF Margin i-4.1%
Debt Repayment i-1.25M-678.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBTLSSYENS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i37.47M101.95M
Float Shares i15.64M69.17M
% Held by Insiders i47.72%31.39%
% Held by Institutions i21.37%35.17%
% Held by Public i30.91%33.44%

Dividend Analysis & Yield Comparison: Biotalys N.V. vs Syneos Health, Inc.

MetricBTLSSYENS
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A